Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Treat_CCM trial of propranolol in familial cerebral cavernous malformation
2017-003595-30Phase 2Completed
- Sponsor
- Mario Negri Institute for Pharmacological Research
- Start
- Jun 2021
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 2, randomised trial of propranolol in familial cerebral cavernous malformation (CCM) (2 arms), sponsored by Mario Negri Institute for Pharmacological Research. Primary endpoint: New CCM-related clinical events. Started Jun 2021; status: completed.
02
Drugs
propranolol
03
Conditions
familial cerebral cavernous malformation (CCM)
Beyond the preview
Go deeper on 2017-003595-30.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2017-003595-30.